Company Filing History:
Years Active: 2021
Title: Koen Raedschelders: Innovator in Cardiovascular Disease Assessment
Introduction
Koen Raedschelders is a notable inventor based in Venice, CA, who has made significant contributions to the field of cardiovascular disease risk assessment. His innovative work focuses on the detection of natriuretic peptides, which play a crucial role in diagnosing cardiovascular conditions.
Latest Patents
Raedschelders holds a patent for a method titled "B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment." This patent describes methods for assessing the risk of cardiovascular disease in individuals by detecting the presence of cleavage products of natriuretic peptides over time. The presence of these products indicates an increased risk of developing cardiovascular disease. Additionally, the patent includes compositions and kits that utilize non-natural natriuretic peptides comprising D-amino acids, which can be used for diagnosing and treating diseases.
Career Highlights
Koen Raedschelders is affiliated with Cedars-Sinai Medical Center, where he continues to advance research in cardiovascular health. His work has the potential to improve diagnostic methods and treatment options for patients at risk of cardiovascular diseases.
Collaborations
Raedschelders collaborates with esteemed colleagues such as Shenyan Zhang and Jennifer E Van Eyk, contributing to a dynamic research environment focused on innovative healthcare solutions.
Conclusion
Koen Raedschelders exemplifies the spirit of innovation in the medical field, particularly in cardiovascular disease assessment. His contributions through patents and collaborations are paving the way for improved diagnostic and treatment methodologies.